STOCKHOLM, SWEDEN, September 27, 2023. Karolinska Development AB announces that its portfolio company OssDsign successfully has completed a directed share issue to a value of approximately SEK 150.
STOCKHOLM, SWEDEN, September 19, 2023. Karolinska Development AB announces that its portfolio company OssDsign has received clearance from FDA for the use of OssDsign Catalyst in interbody cages in.
Karolinska Development s portfolio company OssDsign has received FDA clearance for a new major indication orthospinenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from orthospinenews.com Daily Mail and Mail on Sunday newspapers.
Karolinska Development s portfolio company OssDsign has received FDA clearance for a new major indication sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.
STOCKHOLM – 25 August 2023. Karolinska Development AB today publishes its Interim Report - January-June 2023. The full report is available on the Company s website. “Our portfolio companies.